Skip to content
Trial Agents

Caerus Marketing Group

Caerus Marketing Group is recorded as a service provider in 5 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

5distinct trials
2recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 5 of 5 trials · Latest update first

A Phase III, Open-Label, Multicenter, Randomized Study Evaluating the Efficacy and Safety of Glofitamab in Combination with Gemcitabine Plus Oxaliplatin Versus Rituximab in Combination with Gemcitabine and Oxaliplatin in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Sponsor F. Hoffmann-La Roche AG

Start (EU)
Latest update
Estimated end

A Multi-Center, Randomized, Double-Blind, Placebo- and Active-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Naïve to Biologic Disease-Modifying Antirheumatic Drugs (LATITUDE-PsA-3001)

Sponsor Takeda Development Center Americas Inc.

Start (EU)
Latest update
Estimated end

Questions about this trial experience

What services are recorded for Caerus Marketing Group?

The 2026-10-09 snapshot links Caerus Marketing Group to 5 distinct CTIS trials. Recorded services include Patient Recruitment, Patient App electronic capture of daily MMF dosing & daily urine monitoring reading. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Caerus Marketing Group?

The most frequently recorded therapeutic areas are Dermatology, Haematological Malignancies, Immunology, Nephrology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Caerus Marketing Group conducted?

The linked trials record locations in 15 countries, including Spain, Belgium, Germany, France, Poland. These are trial locations, not confirmed office locations or countries where Caerus Marketing Group delivered services.

What can this page tell me about Caerus Marketing Group's trial experience?

Browse 5 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Caerus Marketing Group. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Caerus Marketing Group LLC

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.